SCHEMBL23874010

SCHEMBL23874010

c1ccc(-c2nc3cc(-n4c(-c5ccc(-c6nc7ccccc7n6-c6ccc7[nH]cnc7c6)cc5)nc5ccccc54)ccc3[nH]2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ NPC1 O15118 6/20 0.42
▸ RAB9A P51151 6/20 0.42
▸ GAA P10253 1/20 0.42
▸ GRIA1 P42261 1/20 0.41
▸ CACNG8 Q8WXS5 1/20 0.41
▸ CACNG2 Q9Y698 1/20 0.41
▸ AOC2 O75106 1/20 0.40
▸ PTGS2 P35354 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ PDE10A Q9Y233 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23873951 0.79 ESR1 (0.56) ESR1ESR2NPC1RAB9AGAA
SCHEMBL459808 0.79 NPC1 (0.54) NPC1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL27154645 0.78 NPC1 (0.55) ESR1ESR2NPC1RAB9AGAA
SCHEMBL23874038 0.77 HDAC6 (0.53) ESR1ESR2NPC1RAB9AGRIA1
SCHEMBL14669372 0.76 NPC1 (0.49) NPC1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL2686936 0.74 NPC1 (0.54) NPC1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL27154669 0.74 HDAC6 (0.52) NPC1RAB9ASMN1; SMN2PDE10APOLB
SCHEMBL30832862 0.73 CRBN (0.46) ESR1ESR2NPC1RAB9AAOC2
SCHEMBL30822560 0.73 NPC1 (0.56) NPC1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL2569383 0.73 NPC1 (0.56) NPC1RAB9AGAAKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2024-02-27 — — US disclosed
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2024-02-27 — — US disclosed
US-20210301085-A1 POLYMERS DERIVED FROM 2,2'-BISIMIDAZOLES UNITED STATES DEPARTMENT OF ENERGY 2021-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210301085-A1 POLYMERS DERIVED FROM 2,2'-BISIMIDAZOLES PARG, PARN, NOP2 ESR1 2764/4885ESR2 2825/4885NPC1 4196/4885
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles PARG, PARN, NOP2 ESR1 2792/4885ESR2 2910/4885NPC1 4205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback